Clinical Trial Update: Neoadjuvant Treatment Modalities in Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating neoadjuvant treatment modalities for esophageal cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Esophagogastric Junction Cancer

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer, Chemotherapy Effect | Phase 3 | Status: RECRUITING